Adult
Aged
Aged, 80 and over
Cross-Sectional Studies
Female
Genetic Markers
Genetic Predisposition to Disease
Genotype
Humans
Longitudinal Studies
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
/ epidemiology
Obesity
/ complications
Overweight
/ complications
Polymorphism, Single Nucleotide
Prevalence
ROC Curve
Receptors, Adrenergic, beta-3
/ genetics
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
07
2019
revised:
16
10
2019
accepted:
26
11
2019
entrez:
14
1
2020
pubmed:
14
1
2020
medline:
12
5
2020
Statut:
epublish
Résumé
Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases. Obesity is the most common and well-established risk factor for NAFLD, but there are large interindividual differences in the relationship between weight status and the development of NAFLD. Beta-3-adrenergic receptor (ADRB3) plays a key role in the development of visceral obesity and insulin resistance; however, the effect of
Identifiants
pubmed: 31929840
doi: 10.1155/2019/4065327
pmc: PMC6942826
doi:
Substances chimiques
ADRB3 protein, human
0
Genetic Markers
0
Receptors, Adrenergic, beta-3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4065327Informations de copyright
Copyright © 2019 Yuki Sakamoto et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Dis Markers. 2018 Sep 23;2018:8635329
pubmed: 30344796
Science. 2002 Aug 2;297(5582):843-5
pubmed: 12161655
Cells. 2019 Apr 16;8(4):
pubmed: 30995798
Int J Mol Sci. 2016 Jul 22;17(7):
pubmed: 27455252
J Hepatol. 2017 Oct;67(4):862-873
pubmed: 28642059
N Engl J Med. 1995 Aug 10;333(6):348-51
pubmed: 7609751
N Engl J Med. 1995 Aug 10;333(6):352-4
pubmed: 7609752
J Clin Invest. 1993 Jan;91(1):344-9
pubmed: 8380813
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42
pubmed: 27729660
Lipids Health Dis. 2018 Mar 27;17(1):58
pubmed: 29587766
Obes Res. 2001 Dec;9(12):741-5
pubmed: 11743057
Int J Obes Suppl. 2014 Jul;4(Suppl 1):S17-20
pubmed: 27152160
Diabetes Care. 2004 Jun;27(6):1487-95
pubmed: 15161807
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
J Endocrinol. 2016 Dec;231(3):259-269
pubmed: 27672060
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):1-22
pubmed: 14647973
Diabetol Int. 2018 Mar 27;9(1):1-45
pubmed: 30603347
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
J Lipid Res. 2015 Oct;56(10):1912-25
pubmed: 26269358
J Diabetes Investig. 2016 May;7(3):338-42
pubmed: 27330719
J Gastroenterol. 2017 Feb;52(2):164-174
pubmed: 27637587
Lancet. 1995 Nov 25;346(8987):1433-4
pubmed: 7475854
Diabetes. 2018 Dec;67(12):2485-2493
pubmed: 30459251
Appl Physiol Nutr Metab. 2016 Mar;41(3):307-14
pubmed: 26888112
Diabetes. 1999 Jan;48(1):117-20
pubmed: 9892231
Rom J Morphol Embryol. 2009;50(2):169-79
pubmed: 19434307
Cardiovasc Diabetol. 2011 Oct 12;10:89
pubmed: 21992420
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Cardiol Rev. 2013 Nov-Dec;21(6):265-9
pubmed: 23707990
J Gastroenterol Hepatol. 2012 Oct;27(10):1555-60
pubmed: 22741595
Gut. 2017 Jun;66(6):1138-1153
pubmed: 28314735
CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):384-393
pubmed: 29569850
Diabetes Care. 2015 Jan;38(1):150-8
pubmed: 25538311
Gastroenterology. 2014 Mar;146(3):726-35
pubmed: 24316260
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
J Clin Endocrinol Metab. 2013 Jul;98(7):E1272-7
pubmed: 23640967
Methods Mol Biol. 2017;1666:557-580
pubmed: 28980265
Metabolism. 2003 Sep;52(9):1096-101
pubmed: 14506613
Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):106S-110S
pubmed: 15318095
EMBO J. 1991 Dec;10(12):3721-7
pubmed: 1718744
Gastroenterology. 2016 Jun;150(8):1769-77
pubmed: 26928243
Diabetologia. 1997 Apr;40(4):469-72
pubmed: 9112025
Environ Health Prev Med. 2010 Nov;15(6):392-7
pubmed: 21432572
Diabetes. 2017 Aug;66(8):2241-2253
pubmed: 28490610
Obes Res Clin Pract. 2011 Apr-Jun;5(2):e79-e156
pubmed: 24331062
Metabolism. 2008 Nov;57(11):1570-5
pubmed: 18940396
BMC Complement Altern Med. 2018 Jan 24;18(1):26
pubmed: 29361938
Diabetes Res Clin Pract. 2017 Jul;129:86-96
pubmed: 28521197
PLoS One. 2015 Jul 22;10(7):e0132640
pubmed: 26200108
Int J Obes (Lond). 2008 Aug;32(8):1240-9
pubmed: 18574485
N Engl J Med. 1995 Aug 10;333(6):343-7
pubmed: 7609750